These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35619122)

  • 1. BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1.
    Zhang Y; Yang M; Zhang S; Yang Z; Zhu Y; Wang Y; Chen Z; Lv X; Huang Z; Xie Y; Cai L
    Cell Biosci; 2022 May; 12(1):70. PubMed ID: 35619122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic-helix-loop-helix family member e41 suppresses osteoclastogenesis and abnormal bone resorption disease via NFATc1.
    Zhang Y; Li X; Lang J; Li W; Huang D; Sun W; Yang L; Li W; Wang Y; Zhang L
    iScience; 2024 Mar; 27(3):109059. PubMed ID: 38375236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition.
    Yuan L; Zhao N; Wang J; Liu Y; Meng L; Guo S; Wiemer EAC; Chen Q; Mao Y; Ben J; Ma J
    Theranostics; 2021; 11(15):7247-7261. PubMed ID: 34158848
    [No Abstract]   [Full Text] [Related]  

  • 4. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
    Jeong BC; Kim JH; Kim K; Kim I; Seong S; Kim N
    Bone; 2017 Feb; 95():33-40. PubMed ID: 27829167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDK2 Deficiency Prevents Ovariectomy-Induced Bone Loss in Mice by Regulating the RANKL-NFATc1 Pathway During Osteoclastogenesis.
    Lee JM; Kim MJ; Lee SJ; Kim BG; Choi JY; Lee SM; Ham HJ; Koh JM; Jeon JH; Lee IK
    J Bone Miner Res; 2021 Mar; 36(3):553-566. PubMed ID: 33125772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role of helix-loop-helix transcriptional factor Bhlhe40 in osteoclast activation.
    Hirata H; Kamohara A; Murayama M; Nishioka K; Honda H; Urano Y; Soejima H; Oki S; Kukita T; Kawano S; Mawatari M; Kukita A
    J Cell Physiol; 2022 Oct; 237(10):3912-3926. PubMed ID: 35908202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
    Cao B; Dai X; Wang W
    J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective entry into mitosis 1 (Dim1) negatively regulates osteoclastogenesis by inhibiting the expression of nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1).
    An D; Kim K; Lu W
    J Biol Chem; 2014 Aug; 289(35):24366-73. PubMed ID: 25023277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhizae Radix Inhibits Osteoclast Differentiation by Inhibiting c-Fos-Dependent NFATc1 Expression.
    Rho TW; Lee SY; Han SY; Kim JH; Lee KH; Kim DS; Kwak HB; Kim YK
    Am J Chin Med; 2017; 45(2):283-298. PubMed ID: 28231743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat.
    Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS
    J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.
    Yamashita T; Yao Z; Li F; Zhang Q; Badell IR; Schwarz EM; Takeshita S; Wagner EF; Noda M; Matsuo K; Xing L; Boyce BF
    J Biol Chem; 2007 Jun; 282(25):18245-18253. PubMed ID: 17485464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
    Zhuang J; Ning H; Wang M; Zhao W; Jing Y; Liu X; Zu J; Kong P; Wang X; Sun C; Yan J
    Cell Signal; 2021 Nov; 87():110137. PubMed ID: 34469786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis.
    Kim M; Kim HS; Kim JH; Kim EY; Lee B; Lee SY; Jun JY; Kim MB; Sohn Y; Jung HS
    BMC Complement Med Ther; 2020 Feb; 20(1):35. PubMed ID: 32024503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Function of RUNX2 in Regulating Osteoclast Differentiation via the AKT/NFATc1/CTSK Axis.
    Xin Y; Liu Y; Liu D; Li J; Zhang C; Wang Y; Zheng S
    Calcif Tissue Int; 2020 May; 106(5):553-566. PubMed ID: 32008052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
    Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
    J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.
    Tran PT; Dang NH; Kim O; Van Cuong P; Dat NT; Hwangbo C; Van Minh C; Lee JH
    Phytomedicine; 2019 Jun; 59():152908. PubMed ID: 30981187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.
    Li X; Wang Y; Li L; Zhou S; Zhao F
    Cell Biol Toxicol; 2021 Dec; 37(6):849-871. PubMed ID: 33423118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.